CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
58 hedge funds and large institutions have $72.5M invested in Crescent Biopharma, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 29 closing their positions.
Holders
58
Holders Change
-20
Holders Change %
-25.64%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
15
Reduced
22
Closed
29
Calls
$1.06M
Puts
$931K
Net Calls
+$132K
Net Calls Change
+$364K
Top Buyers
1 |
1
Millennium Management
New York
|
$1.59M |
2 |
2
Acadian Asset Management
Boston,
Massachusetts
|
$4.53M |
3 |
E
3
Ergoteles
New York
|
$373K |
4 |
TEE
4
Tibra Equities Europe
London,
United Kingdom
|
$316K |
5 |
5
Renaissance Technologies
New York
|
$1.76M |